A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia

Leukemia

Volumn 21, Issue 1, 2007, Pages 72-78

  Borriello, A ^a   Locasciulli, A ^b   Bianco, A M ^c   Criscuolo, M ^a   Conti, V ^c   Grammatico, P ^d   Cappellacci, S ^d   Zatterale, A ^e   Morgese, F ^f   Cucciolla, V ^a   Delia, D ^g   Della Ragione, F ^a   Savoia, A ^f  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^c TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e Unit of Cytogenetics   (Italy)

^f UNIVERSITY OF TRIESTE   (Italy)

^g NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; FANCONI ANEMIA COMPLEMENTATION GROUP A; FANCONI ANEMIA COMPLEMENTATION GROUP D2; FANCONI ANEMIA COMPLEMENTATION GROUP G; FANCONI ANEMIA GROUP D2 PROTEIN; ISOPROTEIN; LEUCINE; MITOMYCIN C; MUTANT PROTEIN; SERINE; STEROID; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHILDHOOD LEUKEMIA; CHROMOSOMAL INSTABILITY; CLINICAL FEATURE; DISEASE SEVERITY; DRUG SENSITIVITY; FANCONI ANEMIA; HOMOZYGOSITY; HUMAN; HUMAN CELL; IONIZING RADIATION; MALE; MISSENSE MUTATION; MOLECULAR EVOLUTION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PANCYTOPENIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STABILITY; RADIOSENSITIVITY; SCHOOL CHILD; T CELL LEUKEMIA; TRANSCRIPTION REGULATION; UBIQUITINATION;

EID: 33845546512     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404468     Document Type: Article

References (33)

1. Taniguchi T, D'Andrea AD. Molecular pathogenesis of Fanconi anemia: recent progress. Blood 2006; 107: 4223-4233.
2. Kupfer GM, Naf D, Suliman A, Pulsipher M, D'Andrea AD. The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex. Nat Genet 1997; 17: 487-490.
3. de Winter JP, van der Weel L, de Groot J, Stone S, Waisfisz Q, Arwert F et al. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet 2000; 9: 2665-2674.
4. Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 2001; 7: 249-262.
5. Meetei AR, Levitus M, Xue Y, Medhurst AL, Zwaan M, Ling C et al. X-linked inheritance of Fanconi anemia complementation group B. Nat Genet 2004; 36: 1219-1224.
6. Meetei AR, de Winter JP, Medhurst AL, Wallisch M, Waisfisz Q, van de Vrugt HJ et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet 2003; 35: 165-170.
7. Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002; 297: 606-609.
8. Venkitaraman AR. Tracing the network connecting BRCA and Fanconi anaemia proteins. Nat Rev Cancer 2004; 4: 266-276.
9. Litman R, Peng M, Jin Z, Zhang F, Zhang J, Powell S et al. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 2005; 8: 255-265.
10. Levran O, Attwooll C, Henry RT, Milton KL, Neveling K, Rio P et al. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet 2005; 37: 931-933.
11. Levitus M, Waisfisz Q, Godthelp BC, de Vries Y, Hussain S, Wiegant WW et al. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat Genet 2005; 37: 934-935.
12. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003; 101: 822-826.
13. Houghtaling S, Timmers C, Noll M, Finegold MJ, Jones SN, Meyn MS et al. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev 2003; 17: 2021-2035.
14. Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, Joenje H et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med 2003; 9: 568-574.
15. van der Heijden MS, Yeo CJ, Hruban RH, Kern SE. Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Res 2003; 63: 2585-2588.
16. Lensch MW, Tischkowitz M, Christianson TA, Reifsteck CA, Speckhart SA, Jakobs PM et al. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia. Blood 2003; 102: 7-16.
17. Condie A, Powles RL, Hudson CD, Shepherd V, Bevan S, Yuille MR et al. Analysis of the Fanconi anaemia complementation group A gene in acute myeloid leukaemia. Leuk Lymphoma 2002; 43: 1849-1853.
18. Tischkowitz MD, Morgan NV, Grimwade D, Eddy C, Ball S, Vorechovsky I et al. Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia. Leukemia 2004; 18: 420-425.
19. Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer 2003; 97: 425-440.
20. Goldsby RE, Perkins SL, Virshup DM, Brothman AR, Bruggers CS. Lymphoblastic lymphoma and excessive toxicity from chemotherapy: An unusual presentation for Fanconi anemia. J Pediatr Hematol Oncol 1999; 21: 240-243.
21. Shimamura A, De Oca RM, Svenson JL, Haining N, Moreau LA, Nathan DG et al. A novel diagnostic screen for defects in the Fanconi anemia pathway. Blood 2002; 100: 4649-4654.
22. Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 1993; 21: 731-733.
23. Della Ragione FD, Russo GL, Oliva A, Mercurio C, Mastropietro S, Pietra VD et al. Biochemical characterization of p16INK4- and p18-containing complexes in human cell lines. J Biol Chem 1996; 271: 15942-15949.
24. Della Ragione F, Russo GL, Oliva A, Mastropietro S, Mancini A, Borrelli A et al. 5′-Deoxy-5′-methylthioadenosine phosphorylase and p16INK4 deficiency in multiple tumor cell lines. Oncogene 1995; 10: 827-833.
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
26. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4354.
27. Savino M, Borriello A, D'Apolito M, Criscuolo M, Del Vecchio M, Bianco AM et al. Spectrum of FANCA mutations in Italian Fanconi anemia patients: Identification of six novel alleles and phenotypic characterization of the S858R variant. Hum Mutat 2003; 22: 338-339.
28. Yamashita T, Barber DL, Zhu Y, Wu N, D'Andrea AD. The Fanconi anemia polypeptide FACC is localized to the cytoplasm. Proc Natl Acad Sci USA 1994; 91: 6712-6716.
29. Xu B, Kim S, Kastan MB. Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol Cell Biol 2001; 21: 3445-3450.
30. Dequen F, St-Laurent JF, Gagnon SN, Carreau M, Desnoyers S. The Caenorhabditis elegans FancD2 ortholog is required for survival following DNA damage. Comp Biochem Physiol B Biochem Mol Biol 2005; 141: 453-460.
31. Taniguchi T, Garcia-Higuera I, Xu B, Andreassen PR, Gregory RC, Kim ST et al. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. Cell 2002; 109: 459-472.
32. Timmers C, Taniguchi T, Hejna J, Reifsteck C, Lucas L, Bruun D et al. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell 2001; 7: 241-248.
33. Hirsch B, Shimamura A, Moreau L, Baldinger S, Hag-Alshiekh M, Bostrom B et al. Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. Blood 2004; 103: 2554-2559.